Abstract:
This audit involves two detailed approaches, mucoadhesion and thermal gelling, which have been proposed to slow the vaginal mucosa from clinical devices or drug delivery frames to improve their viability. After a precise presentation the study manages the aforementioned transport frames of the vaginal condition and in particular the vaginal emissions which have a strong influence on the in vivo performance of the vaginal definitions. The usual rates (gels, tablets, suppositories and emulsions) and the new drug transport frames (small, nanoparticles) that are supposed to be similar or fundamental for the mucoadhesive frames. The effect of this is on the vaginal organization. The polar-based concepts (ethylene oxide-propylene oxide-ethylene oxide-oxide) and chitosan-based copolymers are investigated as thermosetting reinforcements for thermogellating reinforcements. The techniques employed in making mucoadhesive and thermogellating drug delivery structures useful are also briefly described.
|